FibroGen Inc. | Key People and Executives
Thomas Byron Neff
Chairman & Chief Executive Officer
Gerald Lema
Independent Director
Jeffrey William Henderson
Independent Director
Thomas F. Kearns
Independent Director
Jeffrey L. Edwards
Independent Director
Rory B. Riggs
Independent Director
Kalevi Kurkijärvi
Independent Director
Jorma Tapio Routti
Independent Director
Roberto Pedro Rosenkranz
Independent Director
Toshinari Tamura
Independent Director
James A. Schoeneck
Independent Director
Thomas Byron Neff
Chairman & Chief Executive Officer
Pat Cotroneo
Chief Financial Officer & Vice President-Finance
Kin Hung Yu
Chief Medical Officer
Seth Porter
Vice President-Fibrosis Therapeutics
Christine L. Chung
Vice President-China Operations
Elias Kouchakji
VP-Clinical Development
Michael Martinelli
Vice President-Technical Development
Al Lin
Vice President-Drug Development
Leanne C. Price
Chief Intellectual Property Counsel
R. Wayne Frost
Vice President-Regulatory Affairs
Karen L. Bergman
Vice President-Investor Relations & Communications
Richard A. Farley
Vice President-Human Resources
Julian N. Stern
Secretary
Michael D. Lowenstein
Chief Legal Counsel
Gerald Lema
Independent Director
Jeffrey William Henderson
Independent Director
Thomas F. Kearns
Independent Director
Jeffrey L. Edwards
Independent Director
Rory B. Riggs
Independent Director
Kalevi Kurkijärvi
Independent Director
Jorma Tapio Routti
Independent Director
Roberto Pedro Rosenkranz
Independent Director
Toshinari Tamura
Independent Director
James A. Schoeneck
Independent Class I Director
| Address |
409 Illinois Street
San Francisco California 94158
United States
|
|
Employees
|
- |
| Website |
http://www.fibrogen.com |
| Updated |
07/08/2019 |
| FibroGen, Inc. engages in the discovery, development, and commercialization of therapeutics to treat unmet medical needs. It focuses on fibrosis and hypoxia-induced factor biology to generate programs targeting therapeutic areas. The company was founded by Thomas B. |
